Roche drops India patent for breast-cancer drug (Update)
Swiss pharmaceutical giant Roche says it is abandoning a patent for top-selling breast cancer drug Herceptin in the Indian market, paving the way for local drugmakers to make a cheaper generic version.
Aug 17, 2013